发明申请
- 专利标题： Hydrophilic/Lipophilic Polymeric Matrix Dosage Formulation
- 专利标题（中）： 亲水/亲脂性聚合物基质剂配方
-
申请号： US13022281申请日： 2011-02-07
-
公开(公告)号： US20110177167A1公开(公告)日： 2011-07-21
- 发明人: Guy Vergnault , Pascal Grenier , Lauretta Maggi , Ubaldo Conte
- 申请人： Guy Vergnault , Pascal Grenier , Lauretta Maggi , Ubaldo Conte
- 申请人地址： CH Muttenz
- 专利权人： Jagotec AG
- 当前专利权人： Jagotec AG
- 当前专利权人地址： CH Muttenz
- 优先权： ITM12000A000852 20000414; ITM12000A001963 20000907
- 主分类号： A61K9/24
- IPC分类号： A61K9/24 ; A61K31/505 ; A61K31/5377 ; A61K31/404 ; A61P9/00
摘要：
An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials, and adjuvant substances. The tablets of the present invention show a release rate which is independent from the amounts of active substance present in the tablet.
公开/授权文献
- US08460706B2 Hydrophilic/lipophilic polymeric matrix dosage formulation 公开/授权日：2013-06-11
信息查询
